Valley Financial Management’s VanEck Biotech ETF BBH Stock Holding History

Valley Financial Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2.75M	Buy	17,652 +284	+2%	+$45.4K	1.43%	24
2023 Q1	$2.82M	Buy	17,368 +4,227	+32%	+$684K	1.74%	22
2022 Q4	$2.1M	Buy	13,141 +847	+7%	+$134K	1.17%	22
2022 Q3	$1.73M	Buy	+12,294	New	+$1.86M	1.04%	23

Other funds holding BBH

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Valley Financial Management's BBH Position: Q2 2023 in Review

Valley Financial Management increased its VanEck Biotech ETF (BBH) stake by 1.6% in Q2 2023, buying an estimated $45.4K and bringing the position to 17,652 shares worth $2.75M. The position accounts for 1.43% of the portfolio, ranked #24.

Valley Financial Management first reported a position in BBH in Q3 2022 and has held it in 4 quarters since. The position peaked at $2.82M in Q1 2023. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2023.

Valley Financial Management held 17,652 shares of VanEck Biotech ETF worth $2.75M as of Q2 2023.
Valley Financial Management bought 284 VanEck Biotech ETF shares in Q2 2023, an estimated $45.4K.
VanEck Biotech ETF made up 1.43% of Valley Financial Management's portfolio in Q2 2023, its #24 holding.
Valley Financial Management first reported a position in VanEck Biotech ETF in Q3 2022 and has held it in 4 quarters since.
Valley Financial Management's VanEck Biotech ETF position peaked at $2.82M in Q1 2023.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2023.

Based on Valley Financial Management's 13F filing for Q2 2023, filed 14 Aug 2023.